Biodel Inc. (NASDAQ: BIOD) will present data from human and animal studies with its ultra-rapid-acting/basal insulin and glucagon product candidates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE